Bloodworks 101

ENCORE "When a Platelet Donor Meets a Recipient" - Dr. Moritz Stolla, Dan Ertel & Mack Bell

March 14, 2024 Bloodworks Northwest
ENCORE "When a Platelet Donor Meets a Recipient" - Dr. Moritz Stolla, Dan Ertel & Mack Bell
Bloodworks 101
More Info
Bloodworks 101
ENCORE "When a Platelet Donor Meets a Recipient" - Dr. Moritz Stolla, Dan Ertel & Mack Bell
Mar 14, 2024
Bloodworks Northwest

Got a story idea for Bloodworks 101? Send us a text message

It's rare that a blood donor and a recipient get to connect but that's exactly what happens on this special ENCORE episode of Bloodworks 101 when frequent platelet donor Dan Ertel meets Mack Bell, a 30-year-old African-American man living with cerebral palsy, who contracted a potentially-deadly blood condition called aplastic anemia. That's a deficiency of all types of blood cells caused by failure of bone marrow development.
Mack, as you'll discover,  was the recipient of several transfusions that played a big role in the effort to save his life. So, here's what happens when someone with a lot to be grateful for gets to thank someone who wasn't expecting it.
But there's more. Wait til you hear what's happened since this story first ran in January of 2022. 

Show Notes

Got a story idea for Bloodworks 101? Send us a text message

It's rare that a blood donor and a recipient get to connect but that's exactly what happens on this special ENCORE episode of Bloodworks 101 when frequent platelet donor Dan Ertel meets Mack Bell, a 30-year-old African-American man living with cerebral palsy, who contracted a potentially-deadly blood condition called aplastic anemia. That's a deficiency of all types of blood cells caused by failure of bone marrow development.
Mack, as you'll discover,  was the recipient of several transfusions that played a big role in the effort to save his life. So, here's what happens when someone with a lot to be grateful for gets to thank someone who wasn't expecting it.
But there's more. Wait til you hear what's happened since this story first ran in January of 2022.